News (421)

3 Trends In Healthcare Guided By AI And The Companies Behind The Innovation AQ
Moderna : 2024 Proxy Statement PU
IR Insights: Recapping our Fifth Annual Vaccines Day PU
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program BU
Next-gen Moderna COVID-19 vaccine shows promise AQ
Moderna, Inc. AQ
Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector MT
Moderna : 2023 Shareholder Letter PU
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence MT
Moderna Announces Changes to Commercial Organization CI
Moderna, Inc. AQ
Moderna, Inc. : melts like snow in the sun Our Logo
Stéphane Bancel, CEO of Moderna: sales down, restructuring underway, acquisitions to come MT
Moderna, Inc. AQ
Moderna reveals optimistic data for influenza-COVID-19 vaccine AQ
Moderna, Inc. AQ
INTERVIEW - Stéphane Bancel, CEO of Moderna: towards $15 billion in annual revenues over the next few years MT
Moderna : 2Q 2023 Earnings Call Presentation PU
Moderna seeks regulatory approval of RSV vaccine for people 60 and older AQ
Moderna, Inc. AQ
Moderna, Inc. AQ
Moderna submits updated COVID-19 vaccine to FDA AQ
Moderna : 1Q 2023 Earnings Call Presentation PU
Moderna : Company in negotiations for new orders for fall of 2023 in U.S., Japan, and E.U., in addition to reiterating 2023 minimum sales expectations of approximately $5.0 billion from previously announced COVID-19 vaccine Advanced Purchase Agreements - Form 8-K PU
Moderna says flu vaccine candidate requires additional study AQ
Moderna, Inc. AQ
Moderna CEO faces Senate panel as price of COVID-19 vaccine set to quadruple AQ
Moderna : 4Q 2022 Earnings Call Presentation PU
Moderna promises free COVID-19 vaccines after U.S. public health emergency ends AQ
MRNA IP 2022 Year In Review: Pioneers Clash In Major Patent Litigations AQ
Moderna : 2022 Shareholder Letter PU
Moderna, Inc. AQ
Moderna, Inc. AQ
Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA BU
Moderna : 3Q 2022 Earnings Call Presentation PU
Moderna : Revenue from advance purchase agreements for anticipated delivery in 2022 expected to be $18 to $19 billion, following delay of certain deliveries into 2023 due to short-term supply constraints - Form 8-K PU
Moderna, Inc. AQ
COVID-19: Is The IP Truce Over? AQ
Moderna : 2022 R&D Day Highlights Moderna’s Broad Portfolio of mRNA Clinical Trial Programs PU
Moderna, Inc. AQ
Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day EQ
Moderna Sues Pfizer / BioNTech For COVID Vaccine Patent Infringement AQ
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union EQ
Moderna sues Pfizer/BioNTech for Covid vaccine infringement AQ
Canada buys up millions more doses of Moderna's bivalent COVID-19 vaccine AQ
1234NextSee all

Companies (228)

MARRIOTT INTERNATIONAL, INC. 66 282 M $
Logo Marriott International, Inc.

Marriott International, Inc. specializes in hotel operating. Net sales break down by activity area as follows: - The United States and Canada (79.9%): - International (20.1%). At the end of 2023, the group operated 8,785 hotels and residences (1,513,9 ...

SANDS CHINA LTD 20 707 M $
Logo Sands China Ltd

Sands China Ltd specializes in developing, owning and operating integrated casinos and recreation complexes located primarily in Macao. Net sales break down by type of assets as follows: - casinos (69.3%): owned, at the end of 2020, 2,722 slot machines a ...

GAMING AND LEISURE PROPERTIES, INC. 12 082 M $
Logo Gaming and Leisure Properties, Inc.

Gaming and Leisure Properties, Inc. is a self-administered and self-managed real estate investment trust. The Company's business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrange ...

THE BERKELEY GROUP HOLDINGS PLC 7 042 M $
Logo The Berkeley Group Holdings plc

The Berkeley Group Holdings plc is a United Kingdom-based company engaged in building homes and neighborhoods across London, Birmingham, and the South of England. The Company and its subsidiaries are engaged in residential-led, mixed-use property developm ...

PERNOD RICARD 38 834 M $
Logo Pernod Ricard

Pernod Ricard is the world's No. 2 in the production and marketing of Premium and Prestige spirits and wines. Net sales break down by family of products as follows: - spirits and champagnes of strategic international brands (63.4%): Absolut (12.7 million ...

HWASEUNG INDUSTRIES CO.,LTD. 144 M $
Logo HWASEUNG Industries Co.,Ltd.

HWASEUNG Industries Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of footwear. The Company operates in three segments: film segment, footwear segment and distribution segment. The film segment provides biaxially ...

ST. ST. CONSTANTINE AND HELENA HOLDING 29 M $
Logo St. St. Constantine and Helena Holding

St St Constantine and Helena Holding AD (Sveti Sveti Konstantin i Elena Holding AD) is a Bulgaria-based holding company that is principally engaged in the management of the resort's territory, hotels, restaurants, infrastructure facilities, commercial out ...

KNUTSFORD EXPRESS SERVICES LIMITED 37 M $
Logo Knutsford Express Services Limited

Knutsford Express Services Limited is a Jamaica-based company. The Company's main activities are the provision of transportation and courier services and rental from investment properties. The Company operates through two segments: Transportation & Courie ...

MINOR INTERNATIONAL 4 876 M $
Logo Minor International

Minor International Public Company Limited is a Thailand-based company engaged in the investment activities, hotels, restaurant operations, and distribution and manufacturing. The Company operates through four segments: Hotel, Mixed use, Restaurant and Re ...

VERTICAL EXPLORATION INC. 3 M $
Logo Vertical Exploration Inc.

Vertical Exploration Inc. is a junior mining company with exploration and evaluation assets in Canada. The Company is engaged in identifying, acquiring, and advancing mining prospects located in North America for the benefit of its stakeholders. The Compa ...


1234Next

Insiders

Picture Christophe Bancel
Christophe Bancel

Christophe Bancel is the founder.
He founded Tissium SA in 2013, where he currently holds the title of Chief Executive Officer & Director.
He also founded iBionext SAS in 2012, where he holds the title of Venture Partner.
In addition to his founding positions, Mr. Bancel has worked as a Director at Brainever SAS.


Picture François-Alexis Bancel
François-Alexis Bancel

François-Alexis Bancel is currently the Director-Administrative & Finance at PAULIC Meunerie SA since 2016.
He completed his undergraduate degree from NEOMA Business School.


Picture Olivier Bancel
Olivier Bancel

Olivier Bancel has worked as an Executive Director General-Projects & Maintenance at Société Nationale SNCF and as a Chief Operations Officer at SNCF Réseau SA.



Picture Jean-Jacques Bancel
Jean-Jacques Bancel

Jean-Jacques Bancel worked as a Communication Director at Autoroutes du Sud de la France SA, Financial Director at Bonna Sabla SA and ASF Group Ltd., Principal at HSBC Continental Europe and Mars & Co. He also served as the Chief Financial Officer & Executive Vice President at Ethypharm SAS and as the Chief Financial Officer at Solocal Group.
Bancel completed his undergraduate degree from ESSEC Business School.


Picture Jean-Louis Bancel
Jean-Louis Bancel

Jean-Louis Bancel is currently the Chairman at Crédit Coopératif SA. He also holds the position of Vice Chairman & Secretary at Mutré SA. In addition, he serves as a Director on the Supervisory Board of ESFIN Gestion SA, Matmut VIE, AMF Assurances SAS, Alliance Coopérative Internationale, Finance-Innovation, Université Paris Nanterre, Banque Edel SNC, Office Coordination Bancaire Financiere, Coop Fr, and Mutuelle Centrale des Finances.
Previously, Mr. Bancel served as the Chairman of the Supervisory Board at Banque du Bâtiment et des Travaux Publics SA. He was also a Director on the Supervisory Board of Matmut Assurances SA, Groupe IRD SA, and Compagnie Européenne de Garanties et Cautions SA.


Picture Frederic Bancel
Frederic Bancel

Frederic Bancel has been a Director at Bancel since 2008.



Stéphane Bancel
Stéphane Bancel

Stéphane Bancel is a businessperson who has been the head of 5 different companies. Presently, he occupies the position of Chief Executive Officer & Director at Moderna, Inc., Chief Executive Officer & Director at ModernaTX, Inc. (a subsidiary of Moderna, Inc.) and Chief Executive Officer at Moderna SpA. Mr. Bancel is also on the board of 5 other companies. In his past career Stéphane Bancel occupied the position of Chairman at BG Medicine, Inc., Executive Director-Global Manufacturing Strategy at Eli Lilly & Co. Principal at Eli Lilly & Co. Ltd. and Managing Director at Eli Lilly Benelux SA (both are subsidiaries of Eli Lilly & Co.) and Chief Executive Officer for bioMérieux SA. Stéphane Bancel received a graduate degree from the University of Minnesota, a graduate degree from École Centrale Paris and an MBA from Harvard Business School.

No results for this search